Johnson & Johnson - Ebitda

Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Ebitda" stands at 33.73 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026.

Johnson & Johnson's second quarter result of 8.99 Billion USD for the item "Ebitda" represents an increase of 8.72 percent compared to it's first quarter result.

Also, Johnson & Johnson's second quarter result of 8.99 Billion USD for the item "Ebitda" represents an increase of 2.80 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Johnson & Johnson's second quarter result of 33.73 Billion USD for the item "Ebitda" represents an increase of 0.73 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.37 percent compared to the value the year prior.
The 1 year change in percent is -5.37.
The 3 year change in percent is 44.18.
The 5 year change in percent is 21.06.
The 10 year change in percent is 50.16.

The Serie's long term average value is 25.67 Billion United States Dollars. It's latest available value, on 06/30/2026, is 31.39 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2012, to it's latest available value, on 06/30/2026, is +123.78%.
The Serie's change in percent from it's maximum value, on 12/31/2025, to it's latest available value, on 06/30/2026, is -17.38%.